City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
Click here to login to Secure Web Site  (authorized users only)  
  
Search results:  253  Clinical trial(s) found  (Page 1 of 51 )
  [Next>]
Click here to generate a printer-friendly view  
The following studies are available for :
 09205
   P.I.: Katherine Henderson, PhD
Title: The Love/Avon Army of Women Health Study, Phase II
 09196
   P.I.: Marianna Koczywas, MD
Title: A Non-Randomized, Open Label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Saftey of STA-9090 in Subjects with Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
 
Click here for  Full Eligibility Criteria
 09181
   P.I.: Melanie Palomares, MD, MS
Title: A Randomized Controlled Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women (Novel Markers Trial/NMT)
 09169
   P.I.: Susan Neuhausen, PhD
Title: Genetic Epidemiology of Celiac Disease
 09161
   P.I.: George Somlo, MD
Title: Role of Stat3 in Human Breast Cancer as a Target of Cancer Therapy
  [Next>]

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.